SLDB - Solid Biosciences LLC logo

SLDB

Solid Biosciences LLC

Solid Biosciences develops gene therapies for neuromuscular and cardiac diseases, with candidates such as SGT-003 for Duchenne muscular dystrophy. It also works on technologies for gene delivery and collaborates with various academic institutions.

โš•๏ธ Healthcare NASDAQ Listed 2018 $ USD
$1,000 invested 5 years ago โ†’$222today

Score Overview

1 Year
Scoreโ€”
Net Growth-18.80%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growthโ€”
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score0.4
Net Growth-186.89%
Net TrendNever
Net Income Consistencyโ€”
Rev Growth-100.00%
Rev TrendNever
Revenue Consistencyโ€”
All Time
Scoreโ€”
Net Growth-176.88%
Net Trend25%
Net Income Consistency
Rev Growthโ€”
Rev Trend25%
Revenue Consistency

See the full market ranking โ†’

Solid Biosciences LLC fundamental performance

Between 2020 and 2025, revenue declined from $ 3M to $ 0.00 and net income went from -$ 88M to -$ 174M. Revenue increased in 0 of those 5 years; net income in 0.

Solid Biosciences LLC currently holds a 5-year HDB Score of 0.4 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 9.06โ€”
1 Year2025-08-12
$ 6.0450.08%
5 Years2021-08-12
$ 40.80-77.78%
All Time2018-01-26
$ 339.30-97.33%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 0.00-$ 207M$ 377M
2025$ 0.00-$ 174M$ 187M
2024$ 0.00-$ 124M$ 148M
2023$ 0.00-$ 96M$ 123M
2022$ 8M-$ 85M$ 213M
2021$ 13M-$ 72M$ 207M
2020$ 3M-$ 88M$ 154M
2019$ 0.00-$ 117M$ 83M
IPO2018$ 0.00-$ 74M$ 122M

Explore beyond SLDB

You're looking at Solid Biosciences LLC. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies